Financhill
Back

Applied Therapeutics Vs. Cellectar Biosciences Industry Stock Comparison

Sell
27

APLT
Applied Therapeutics

Last Price:
$0.88
Seasonality Move:
5.46%
Sell
37

CLRB
Cellectar Biosciences

Last Price:
$0.24
Seasonality Move:
-2.17%
Sell
27
Applied Therapeutics (APLT) is a Sell

Is Applied Therapeutics a Buy, Sell or Hold?

  • The current Applied Therapeutics [APLT] share price is $0.88. The Score for APLT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $0.24. The Score for CLRB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLT Stock Price Chart

What is Applied Therapeutics's stock price today?

  • The Applied Therapeutics share price today is $0.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLT is experiencing slight selling pressure.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $0.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.

APLT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.82 Sell
Relative Strength Index (14 RSI): 16.8 Sell
Chaikin Money Flow: -6309791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.31 - 7.97) Sell
Bollinger Bands (100): (3.84 - 9.3) Sell

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 6.1 Sell
Chaikin Money Flow: -1047529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.52 - 1.72) Sell
Bollinger Bands (100): (1.33 - 2.35) Sell

APLT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.1 Sell
20-day SMA: 2.93 Sell
50-day SMA: 6.62 Sell
200-day SMA: 5.83 Sell
8-day EMA: 1.23 Sell
20-day EMA: 2.81 Sell
50-day EMA: 5.11 Sell
200-day EMA: 5.55 Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.26 Sell
20-day SMA: 0.98 Sell
50-day SMA: 1.6 Sell
200-day SMA: 2.49 Sell
8-day EMA: 0.41 Sell
20-day EMA: 0.85 Sell
50-day EMA: 1.39 Sell
200-day EMA: 2.17 Sell

Applied Therapeutics Earnings Growth & APLT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.94 per share.

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.

Applied Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):